Iman Jilani

Title: Iman Jilani: Innovator in Cancer Research

Introduction

Iman Jilani is a notable inventor based in Houston, TX (US). She has made significant contributions to the field of cancer research through her innovative work on fusion proteins. Her research focuses on the detection of gene products resulting from chromosomal translocations, which is crucial for cancer prognosis and therapy.

Latest Patents

Iman Jilani holds a patent titled "Quantification of fusion proteins and their activity from chromosomal translocation." This invention concerns the detection of fusion proteins that comprise a first and second region. The method involves subjecting a sample containing these proteins to a bead with an antibody to the first region, followed by a second antibody directed against the second region. This innovative approach aids in providing prognosis for individuals with cancer, identifying suitable therapies, and monitoring patient responses to treatments. She has 1 patent to her name.

Career Highlights

Throughout her career, Iman has worked with prestigious organizations, including the University of Texas System and Quest Diagnostics Incorporated. Her experience in these institutions has allowed her to collaborate with leading experts in the field.

Collaborations

Iman has had the opportunity to work alongside esteemed colleagues such as Hagop M Kantarjian and Maher Albitar. Their collaboration has further advanced the research and application of her innovative methods in cancer detection and treatment.

Conclusion

Iman Jilani's contributions to cancer research through her patent on fusion proteins exemplify her dedication to improving patient outcomes. Her work continues to influence the field and offers hope for advancements in cancer therapy.